Announced Mon, 10 Nov · 22:19 IST
AstraZeneca Pharma India Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Compliance View source PDF
ASTRAZEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve
Awaiting price reaction for this filing.
AI summary
AstraZeneca Pharma India Limited has submitted a certificate to the stock exchange as required under SEBI's Depositories and Participants Regulations, 2018. This is a routine compliance filing confirming adherence to depositary-related rules. No financial figures, transactions, or corporate actions are involved. The filing is purely regulatory in nature and typically does not signal any change in business or operations.
Likely market impact
This is a standard compliance disclosure with no material impact on the company's financials or stock price. Shareholders need not take any action.